Connor, Clark & Lunn Investment Management Ltd.

Position in CTKB — Cytek Biosciences, Inc.

CIK 1596800 VANCOUVER, A1

Position in CTKB

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,182,535

+$127,163 QoQ

Shares Held

266,938

+10.5% QoQ

Ownership

0.205%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#37

of 154 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $204,731,115 across 26 Medical Devices names. CTKB ranks #12 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	869,131	$78,864,946
2	BSX	Boston Scientific Corp	1,467,148	$62,617,875
3	PHG	Koninklijke Philips NV	563,724	$15,327,654
4	SNN	Smith & Nephew PLC	487,774	$14,052,767
5	NVCR	NovoCure Ltd	661,280	$10,018,391
6	IRTC	iRhythm Holdings, Inc.	42,314	$5,033,250
7	AXGN	Axogen, Inc.	67,118	$3,100,180
8	VREX	Varex Imaging Corp	293,435	$3,060,526

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,182,535	266,938	+10.5%	Shares	Sole	2026-08-13
2026-03-31	$1,055,372	241,504	-18.3%	Shares	Sole	2026-05-11
2025-12-31	$1,492,961	295,636	-0.8%	Shares	Sole	2026-02-10
2025-09-30	$1,033,626	297,875	-6.6%	Shares	Sole	2025-11-13
2025-06-30	$1,084,824	319,066	-11.3%	Shares	Sole	2025-08-07
2025-03-31	$1,441,903	359,577	-40.2%	Shares	Sole	2025-05-12
2024-12-31	$3,905,000	601,695	-2.3%	Shares	Sole	2025-02-10
2024-09-30	$3,410,590	615,630	-2.5%	Shares	Sole	2024-11-08
2024-06-30	$3,523,613	631,472	-0.1%	Shares	Sole	2024-08-09
2024-03-31	$4,240,438	631,958	+20.4%	Shares	Sole	2024-05-09
2023-12-31	$4,785,382	524,713	+129.7%	Shares	Sole	2024-02-09
2023-09-30	$1,260,740	228,395	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.